• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Publication
Peer-Reviewed
Evidence-Based OncologyJanuary 2021
Volume 27
Issue 1

Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.

Related Videos
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Rebecca Chacko, MD.
Rebecca Chacko, MD, breast medical oncologist at Henry Ford
Dr CK Wang
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Jade E. Jones, MD
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.